Read-Gene S.A. (WSE:RDG)
Poland
· Delayed Price · Currency is PLN 5.18
+0.02 (0.39%)
Last updated: Apr 29, 2026, 10:00 AM CET
Read-Gene Revenue
In the year 2025, Read-Gene had annual revenue of 15.57M PLN with 17.67% growth. Read-Gene had revenue of 5.19M in the quarter ending December 31, 2025, with 7.79% growth.
Revenue
15.57M
Revenue Growth
+17.67%
P/S Ratio
3.91
Revenue / Employee
778.43K
Employees
20
Market Cap
60.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.57M | 2.34M | 17.67% |
| Dec 31, 2024 | 13.23M | 3.08M | 30.38% |
| Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
| Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
| Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.42B |
| NEUCA | 13.64B |
| Synektik Spólka Akcyjna | 706.45M |
| Celon Pharma | 225.60M |
| Poltreg | 250.00K |
| Genomtec | 15.00K |
| Urteste | 1.80M |
| Sygnis | 11.34M |